In Brief: PACE study suggests cognitive behavioral therapy may help some people with chronic fatigue syndrome – but is no panacea

A study comparing treatments for chronic fatigue syndrome found that cognitive behavioral therapy yielded the best results, but the benefit from any of the treatments was modest.

Content restricted. Requires subscription

Study: Drug Slows Ovarian Cancer Growth

An experimental drug shows promise at slowing the growth of ovarian cancer, a study says. The drug is called olaparib. It blocks a natural enzyme known as PARP (Poly ADP ribose polymerase), making chemotherapy more effective. The drug was tested in a study of 65 women with ovarian cancer. The women received olaparib twice a day for 4 weeks. They were also divided into 2 groups: those who carry a gene mutation known as BRCA 1 or BRCA 2, and those who do not. The treatment was most effective in those with the gene mutation. Tumors shrank for 41% of them. It was also helpful for 24% of those without the mutation. The study appears in The Lancet. HealthDay News reported on it Aug. 21.

Content restricted. Requires subscription